GCM
PSTX

Gladius Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Gladius Capital Management’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,125
Closed -$16.1K – 373
2023
Q2 		$16.1K Buy
+9,125
New +$16.1K ﹤0.01% 227